Characterization and comparison of hypoxia inducing factors on tumor growth and metastasis between two- and three-dimensional cancer models

Glycolysis regulation in tumor‐associated macrophages: Its role in tumor development and cancer treatment

(2023) Guangyi Jiang et al.   INTERNATIONAL JOURNAL OF CANCER

PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α

(2023) Yu Wei et al.   Genes and Diseases

CRISPR/Cas9‐mediated Knockout of SIRT6 Imparts Remarkable Antiproliferative Response in Human Melanoma Cells in vitro and in vivo

(2020) Liz M. Garcia‐Peterson et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer

(2016) S. Y. C. Choi et al.   CLINICAL CANCER RESEARCH

MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis

(2016) Ji Yun Lee et al.   Oncotarget

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

(2016) Xiaoyan Xin et al.   Scientific Reports

Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival

(2015) Franziska Baenke et al.   JOURNAL OF PATHOLOGY

MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies

(2014) GuemHee Baek et al.   Cell Reports

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I

(2013) Peter Ellinghaus et al.   Cancer Medicine

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target

(2012) Marco Gerlinger et al.   JOURNAL OF PATHOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Generating specificity and diversity in the transcriptional response to hypoxia

(2009) Urban Lendahl et al.   NATURE REVIEWS GENETICS